Miquimod cream is an immunomodulatory agent mainly used to treat epidermal lesions such as adult actinic keratosis. The following is the detailed content of its official manual, including important information such as indications, usage and dosage, and safety warnings.

1 Indications

(1) Main indications

Used for the treatment of facial or scalp actinic keratosis in adult patients with normal immune system.

(2) Other indications

Some countries have approved the treatment of superficial basal cell carcinoma and external genital warts.

2 Usage and Dosage

(1) Standard usage

Apply 3 times a week (such as Monday, Wednesday, Friday), apply a thin layer to the affected area before bedtime, keep for 6-10 hours, and then rinse.

(2) Course control

The treatment should last for 16 weeks, and if there is no significant improvement after 8 weeks, the diagnosis needs to be re evaluated.

3 Safety Warning

(1) Local reactions

Common skin reactions such as erythema and desquamation, in severe cases, medication should be suspended until symptoms improve.

(2) System response

Possible flu like symptoms such as fever, fatigue, etc., usually temporary.

4 Contraindications

(1) Absolute taboo

Prohibited for individuals allergic to imiquimod or any excipient ingredients.

(2) Relative taboos

Patients with autoimmune diseases should use caution and closely monitor immune responses.

5 Special populations

(1) Pregnancy period

Animal research shows potential risks, and human data is limited, so it is necessary to weigh the pros and cons when using it.

(2) Lactation period

It is not yet clear whether milk has been secreted, and it is recommended to suspend breastfeeding during the treatment period.

6 Drug Interactions

(1) Local medication

Avoid using it together with other topical medications as it may increase skin irritation.

(2) Immunosuppressants

When used in combination with systemic immunosuppressants, it may affect the efficacy.